CEO Evert B. Schimmelpennink buys $251,411 of LENZ Therapeutics, Inc. (LENZ)

Evert B. Schimmelpennink, chief executive of LENZ Therapeutics, Inc., bought 28,089 shares on the open market on March 27, 2026 at an average of $8.95 a share, for a total of $251,411. The purchase was reported to the SEC on Form 4 on March 30, 2026.

It raised their holding by 57%, to 77,289 shares.

The purchase came after a fall: LENZ Therapeutics, Inc. stock was down 49.8% over the 13 weeks before.

2 other insiders also bought at least $10,000 of LENZ within 30 days, which makes this a cluster buy.

In the 12 months up to this filing, LENZ Therapeutics, Inc. insiders reported 3 open-market purchases and 0 sales.

WallStPal Score: 75 out of 100, because of raised their holding by 57%; 2 other insiders also bought; the stock had fallen 49.8% in the 13 weeks before; bought by a top executive.

What happened next: after 1 month the stock was up 13.7% (4.2 points better than the S&P 500); after 3 months the stock was down 31.3% (46.4 points worse than the S&P 500); after 6 months the stock was down 54.5% (71.9 points worse than the S&P 500). Based on weekly prices from the week of the purchase.

Our read

This one purchase is 69% of all insider buying at LENZ in the past year, the first open-market purchase by Evert B. Schimmelpennink in our records, made after a 49.8% fall in 13 weeks, a setup where insider buying has historically mattered most. Insiders buy for many reasons and can be wrong; one purchase is a reason to look closer, not a reason to buy.

Source: SEC Form 4 filing ↗. This story was written automatically from the filing and weekly price data. Information, not investment advice.

Examples

Big insider purchases have made news before. In January 2016, with bank stocks falling, JPMorgan Chase CEO Jamie Dimon bought 500,000 JPMorgan shares, about $26 million of his own money, and the purchase was widely reported as a sign of confidence.

Explain it like I'm 13

Evert B. Schimmelpennink helps run LENZ Therapeutics, Inc.. Spending $251,411 of their own money on the company's stock is like a coach buying a big stack of tickets to their own team's games: it suggests they think the team will do well. It is not a promise, and insiders can be wrong.

More: all LENZ insider trades · Evert B. Schimmelpennink's track record